Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

Prospective European Multicenter Study on Aortic Valve Replacement: (E-AVR Registry)

A legfontosabb adatok

Ki végzi
University of Parma
Hol
Olaszország1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toboroz
Résztvevők
8000 fő, tervezett
Kezdés
2017. nov. 1.
Várható befejezés
2029. okt.
A vizsgálat típusa
Megfigyeléses
A vizsgált kezelések
  • Aortic valve replacement
A regiszteradat frissítve
2020. április 3.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults having surgery or a catheter procedure to replace the aortic valve, for severe aortic valve stenosis (narrowing) or a failing artificial aortic valve. It collects data and follows people for 5 to 10 years.

Életkor
Over 18 years.
Nem
All sexes.
A betegség stádiuma
Severe aortic valve stenosis, with or without leaking of the valve, or a failing artificial aortic valve. Coronary artery disease is allowed. Valve infection (endocarditis) is allowed. Planned, urgent and emergency procedures can join.
Korábbi kezelés
People with an earlier artificial aortic valve that no longer works well can join.

A részvétel fő kizáró okai

  • Other heart surgery at the same time, such as mitral, tricuspid, aorta or atrial fibrillation surgery (bypass surgery, CABG, is allowed).
  • Surgery on the aortic root at the same time, or widening of the valve ring.
  • Heavily calcified aorta (porcelain aorta).
  • Only leaking of the aortic valve, without narrowing.
  • Catheter valve procedure that needs a surgical cut to reach the artery.

A regiszter feltételei, szó szerint

Mind a 14 feltétel megnézéseKevesebb

Ki vehet részt

  • Age >18 yy
  • Isolated SAVS with or without concomitant aortic valve regurgitation
  • Isolated prosthetic aortic dysfunction
  • SAVS + coronary artery disease (CAD)
  • Prosthetic aortic dysfunction + CAD
  • Elective, urgent and emergent procedures
  • Endocarditic aetiology

Ki nem vehet részt

  • Patients undergoing concomitant mitral valve surgery, or tricuspid valve surgery, or aortic surgery (i.e. composite aortic valve and ascending aorta replacement with or without circulatory arrest), or atrial fibrillation surgery, or any other associated cardiac surgical procedure (with the exception of CABG)
  • Concomitant aortic root procedure (i.e. Bentall operation, David operation, homografts, autografts)
  • Percutaneous TAVR requiring surgical cut-down (i.e. failure to comply with a full percutaneous approach, thus configuring a "hybrid procedure")
  • SAVR with techniques of aortic annular enlargement
  • Porcelain aorta
  • Pure aortic valve regurgitation
  • Patient refusal

Ez a vizsgálat jelenleg itt érhető el: Olaszország.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Traditional and transcatheter surgical treatments of severe aortic valve stenosis (SAVS) are increasing in parallel with the improved life-expectancy. Recent randomized trials (RCTs) reported comparable or non-inferior mortality with transcatheter treatments compared to traditional surgery. However, RCTs have the limitation of being a mirror of the predefined inclusion/exclusion criteria, without reflecting the "real clinical world".

A teljes eredeti leírásKevesebb

Technological improvements have recently allowed the development of minimally invasive surgical accesses and the use of sutureless valves, but their impact on the clinical scenario is difficult to assess because of the monocentric design of published studies and limited sample-size. A prospective multicentre registry including all patients referred for a surgical treatment of SAVS (traditional, through full-sternotomy; minimally-invasive; or transcatheter; with both "sutured" and "sutureless" valves) will provide a "real-world" picture of available results of current surgical options, and will help to clarify the "grey zones" of current guidelines.

E-AVR is a prospective observational open registry designed to collect all data from patients admitted for SAVS, with or without coronary artery disease, in 16 cardiac surgery Centres located in six countries (France, Germany, Italy, Spain, Switzerland, and United Kingdom). Patients will be enrolled over a 2-year period and followed-up for a minimum of 5 years to a maximum of 10 years after enrolment. Outcome definitions are concordant with VARC-2 criteria and established guidelines. Primary outcome is 5-year all-cause mortality. Secondary outcomes aim at establishing "early" 30-day all-cause and cardiovascular mortality, as well as major morbidity, and "late" cardio-vascular mortality, major morbidity, structural and non-structural valve complications, quality of life and echocardiographic results.

The study protocol is approved by Local Ethics Committees. Any formal presentation or publication of data will be considered as a joint publication by the participating physician(s) and will follow the recommendations of the International Committee of Medical Journal Editors (ICMJE) for authorship.

A vizsgálat csoportja

  • Aortic valve replacement patients

    All the patients operated on aortic valve replacement in the study period at all the centers participating in the study

    Kezelés: Aortic valve replacement

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Outcome Comparison of Different Surgical Strategies for the Management of Severe Aortic Valve Stenosis: Study Protocol of a Prospective Multicentre European Registry (E-AVR Registry)
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
Publikációk
A regiszteradat frissítve
2020. április 3.